CTIM-07. PHASE II RANDOMIZED, BLINDED, PLACEBO-CONTROLLED TRIAL TESTING PP65 CMV MRNA DENDRITIC CELL VACCINE AND TETANUS-DIPHTHERIA TOXOID FOR NEWLY DIAGNOSED GBM (ATTAC II, NCT02465268)

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC9660708 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature